Exhibit 1 Segmentation of Global Immunotherapy Drugs Market
Exhibit 2 Market Size Calculation Approach 2020
Exhibit 3 Impact of Launch of Next-Generation Immunotherapies
Exhibit 4 Impact of COVID-19 as Growth Catalyst
Exhibit 5 Impact of Investment in R&D Activities
Exhibit 6 Impact of Mergers & Acquisitions
Exhibit 7 Impact of Prevalence of Cancer & Autoimmune Diseases
Exhibit 8 Impact of Approval of Novel Immunotherapy Drugs
Exhibit 9 Impact of Surge in Adoption of CAR T-cell Therapies
Exhibit 10 Number of CAR T-cell Therapies in Clinical Trials (January 2018)
Exhibit 11 Major Vendors Engaged in CAR T-cell Therapy Development
Exhibit 12 Approved CAR T-cell Therapies
Exhibit 13 Impact of Expensive Nature of Immunotherapy
Exhibit 14 Impact of Personalized Approach through Biomarkers
Exhibit 15 Impact of Time-consuming Production Cycle
Exhibit 16 Global Immunotherapy Drugs Market 2020–2026 ($ billion)
Exhibit 17 Five Forces Analysis 2020
Exhibit 18 Incremental Growth by Product Segment 2020 & 2026
Exhibit 19 Global Monoclonal Antibody Market 2020–2026 ($ billion)
Exhibit 20 Global Immunomodulator Market 2020–2026 ($ billion)
Exhibit 21 Global Funding for Development of Cell Therapy 2017–2020 ($ billion)
Exhibit 22 Revenues of Kymriah and Yescarta ($ million)
Exhibit 23 Global CAR T-cell Therapy Market 2020–2026 ($ billion)
Exhibit 24 Global Other Immunotherapy Drugs Market 2020–2026 ($ billion)
Exhibit 25 Incremental Growth by Application Segment 2020 & 2026
Exhibit 26 Number of Products in Clinical Trials in Oncology Application
Exhibit 27 Global Cancer Immunotherapy Drugs Market 2020-2026 ($ billion)
Exhibit 28 Global Autoimmune & Inflammatory Diseases Immunotherapy Drugs Market 2020-2026 ($ billion)
Exhibit 29 Global Other Immunotherapy Applications Market 2020-2026 ($ billion)
Exhibit 30 Incremental Growth by Geography 2020 & 2026
Exhibit 31 New Cancer Cases Reported in North America 2020
Exhibit 32 Market Share of Major Countries in North America
Exhibit 33 North America Immunotherapy Drugs Market 2020–2026 ($ billion)
Exhibit 34 Incremental Growth in North America 2020 & 2026
Exhibit 35 US Immunotherapy Drugs Market 2020–2026 ($ billion)
Exhibit 36 Immunotherapy Drugs Market in Canada 2020–2026 ($ billion)
Exhibit 37 Market Share of Major Countries in Europe
Exhibit 38 Europe Immunotherapy Drugs Market 2020–2026 ($ billion)
Exhibit 39 Incremental Growth in Europe 2020 & 2026
Exhibit 40 Immunotherapy Drugs Market in Germany 2020–2026 ($ billion)
Exhibit 41 Estimated Number of People Living with Cancer by 2030 (million)
Exhibit 42 UK Immunotherapy Drugs Market 2020–2026 ($ billion)
Exhibit 43 Immunotherapy Drugs Market in France 2020–2026 ($ billion)
Exhibit 44 Per Capita Healthcare Expenditure in Italy between 2016 & 2018 ($)
Exhibit 45 Immunotherapy drugs Market in Italy 2020–2026 ($ billion)
Exhibit 46 Immunotherapy Drugs Market in Spain 2020–2026 ($ billion)
Exhibit 47 Market Share of Major Countries in APAC
Exhibit 48 APAC Immunotherapy drugs Market 2020–2026 ($ billion)
Exhibit 49 Incremental Growth in APAC 2020 & 2026
Exhibit 50 Number of new Types of Cancer Cases reported in China (2020)
Exhibit 51 Immunotherapy Drugs Market in China 2020–2026 (billion)
Exhibit 52 Immunotherapy Drugs Market in India 2020–2026 ($ billion)
Exhibit 53 Immunotherapy Drugs Market in Japan 2020–2026 ($ billion)
Exhibit 54 Immunotherapy Drugs Market in Australia 2020–2026 ($ billion)
Exhibit 55 Number of New Types of Cancer Cases Reported in Australia (2020)
Exhibit 56 Number of New Types of Cancers in South Korea (2020)
Exhibit 57 Immunotherapy Drugs Market in South Korea 2020–2026 ($ billion)
Exhibit 58 New Types of Cancer Cases Reported in Latin America (2020)
Exhibit 59 Market Share of Major Countries in Latin America
Exhibit 60 Latin America Immunotherapy Drugs Market 2020–2026 ($ billion)
Exhibit 61 Incremental Growth in Latin America 2020 & 2026
Exhibit 62 Immunotherapy Drugs Market in Brazil 2020–2026 ($ billion)
Exhibit 63 Number of New Types of Cancer Cases Reported in Mexico (2020)
Exhibit 64 Immunotherapy Drugs Market in Mexico 2020–2026 ($ billion)
Exhibit 65 Immunotherapy Drugs Market in Argentina 2020–2026 ($ billion)
Exhibit 66 Market Share of Major countries in MEA
Exhibit 67 MEA Immunotherapy Drugs Market 2020–2026 ($ billion)
Exhibit 68 Incremental Growth in Middle East & Africa 2020 & 2026
Exhibit 69 Cancer Cases in Key Countries across MEA 2020
Exhibit 70 Immunotherapy Drugs Market in South Africa 2020–2026 ($ billion)
Exhibit 71 Immunotherapy Drugs Market in Saudi Arabia 2020–2026 ($ billion)
Exhibit 72 Number of New Cancer Cases Reported in Turkey (2020)
Exhibit 73 Immunotherapy Drugs Market in Turkey 2020–2026 ($ billion)
Exhibit 74 Global Immunotherapy Drugs Market by Product 2020–2026
Exhibit 75 Global Immunotherapy Drugs Market by Application 2020–2026
LIST OF TABLES
Table 1 Key Caveats
Table 2 Currency Conversion 2013–2020
Table 3 Major Mergers & Acquisitions
Table 4 Major Approved Immunotherapy Drugs
Table 5 CAR T-cell Investigational Products
Table 6 Cost of Kymriah in Different Regions
Table 7 CAGR & Revenue of Approved CAR T-cell Therapies 2018–2020 ($ million)
Table 8 CAGR & Revenue of Other Approved Therapies 2018–2020 ($ million)
Table 9 CAR-T Therapies Approved in Japan Region
Table 10 F. Hoffmann-La Roche: Major Product Offerings
Table 11 Bristol Myers Squibb: Major Product Offerings
Table 12 Merck & Co., Inc.: Major Product Offerings
Table 13 GlaxoSmithKline: Major Product Offerings
Table 14 Novartis: Major Product Offerings
Table 15 AstraZeneca: Major Product Offerings
Table 16 Janssen Pharmaceuticals, Inc.: Major Product Offerings
Table 17 AbbVie: Major Product Offerings
Table 18 Alexion Pharmaceuticals: Major Product Offerings
Table 19 Amgen: Major Product Offerings
Table 20 Bayer: Major Product Offerings
Table 21 Dendreon: Major Product Offerings
Table 22 Dynavax: Major Product Offerings
Table 23 Eli Lilly & Company: Major Product Offerings
Table 24 Elusys Therapeutics, Inc.: Major Product Offerings
Table 25 Gilead Sciences, Inc.: Major Product Offerings
Table 26 Pfizer, Inc.: Major Product Offerings
Table 27 Sanofi: Major Product Offerings
Table 28 Seagen Inc.: Major Product Offerings
Table 29 Teva Pharmaceuticals: Major Product Offerings
Table 30 Global Immunotherapy Drugs Market by 2020–2026 ($ billion) (Geography)
Table 31 North America Immunotherapy Drugs Market 2020–2026 (%)
Table 32 Europe Immunotherapy Drugs Market 2020–2026 (%)
Table 33 APAC Immunotherapy Drugs Market 2020–2026 (%)
Table 34 Latin America Immunotherapy Drugs Market 2020–2026 (%)
Table 35 MEA Immunotherapy Drugs Market 2020–2026 (%)